These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 18773529)
1. Marek's disease vaccines: a solution for today but a worry for tomorrow? Gimeno IM Vaccine; 2008 Jul; 26 Suppl 3():C31-41. PubMed ID: 18773529 [TBL] [Abstract][Full Text] [Related]
2. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses. Buscaglia C; Nervi P; Risso M Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986 [TBL] [Abstract][Full Text] [Related]
3. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens. Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405 [TBL] [Abstract][Full Text] [Related]
4. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines. Reddy SM; Izumiya Y; Lupiani B Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868 [TBL] [Abstract][Full Text] [Related]
5. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens. Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090 [TBL] [Abstract][Full Text] [Related]
6. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts. Schat KA Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression. Faiz NM; Cortes AL; Guy JS; Fogle JE; Gimeno IM Vaccine; 2016 Jul; 34(35):4180-4187. PubMed ID: 27371103 [TBL] [Abstract][Full Text] [Related]
8. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection. Baigent SJ; Smith LP; Nair VK; Currie RJ Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084 [TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat. Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614 [TBL] [Abstract][Full Text] [Related]
10. Dynamic Changes in Viral Loads during Co-Infection with a Recombinant Turkey Herpesvirus Vector Vaccine and Very Virulent Marek's Disease Virus In Vivo. Ding T; Xiong M; Xu Y; Pu X; Wang QS; Xu MR; Shao HX; Qian K; Dang HB; Qin AJ Viruses; 2024 Jun; 16(7):. PubMed ID: 39066205 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens. Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells. Geerligs H; Spijkers I; Rodenberg J Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760 [TBL] [Abstract][Full Text] [Related]
13. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B. Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769 [TBL] [Abstract][Full Text] [Related]
14. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence? Davison F; Nair V Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness of mass vaccination on Marek's disease virus (MDV) outbreaks and detection within a broiler barn: a modeling study. Atkins KE; Read AF; Walkden-Brown SW; Savill NJ; Woolhouse ME Epidemics; 2013 Dec; 5(4):208-17. PubMed ID: 24267877 [TBL] [Abstract][Full Text] [Related]
16. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome. Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904 [TBL] [Abstract][Full Text] [Related]
17. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host. Nair V Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338 [TBL] [Abstract][Full Text] [Related]
18. Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene. Cheng MC; Lai GH; Tsai YL; Lien YY PLoS One; 2024; 19(5):e0303371. PubMed ID: 38728352 [TBL] [Abstract][Full Text] [Related]
19. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens. Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932 [TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens. Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]